Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications section wording was updated to reflect that publications are automatically filled from PubMed, replacing the previous description, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-24T20:53:11.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status notice banner, which previously informed users that information may not be up to date and NIH operations could be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:15:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Deleted the previous ALLELE trial entry for EBV+ PTLD and added a new Phase 3 ALLELE entry with updated study procedures, an enrollment target of 115, expanded locations, and new contact details (Claire Fabre).
    Difference
    3%
    Check dated 2025-11-03T12:54:03.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated page metadata and contact details: added Igor Novitzky Basso, MD and new operating-status notice; updated revision to v3.2.0 with new dates (2025-10-02 to 2030-05-31) and current year specifiers; removed Arjun Law, MD and older revision v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:30:45.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Major update: page revision bumped from v3.0.2 to v3.1.0 with extensive addition of new contact/identifier numbers. No changes detected to pricing or availability; core content update centers on the version and expanded contact details.
    Difference
    0.1%
    Check dated 2025-09-28T10:50:48.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:38:50.000Z thumbnail image

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.